Private Advisor Group, LLC
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 1567755
MORRISTOWN, NJ
Position in ARWR
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$2,473,991
+$1,506,781 QoQ
Shares Held
30,352
+96.8% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#12
of 94 holders
Holding Since
Jun 2020
21 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Private Advisor Group, LLC holds $44,247,243 across 48 Biotechnology names. ARWR ranks #4 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
18,557 | $11,571,031 | |
| 2 | CRSP |
CRISPR Therapeutics AG
|
111,129 | $6,060,975 | |
| 3 | CRMD |
CorMedix Inc.
|
415,406 | $3,260,937 | |
| 4 | ARWR |
Arrowhead Pharmaceuticals, Inc.
This page
|
30,352 | $2,473,991 | |
| 5 | TLX |
Telix Pharmaceuticals Ltd
|
197,250 | $2,274,292 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,130 | $2,051,494 | |
| 7 | IBRX |
ImmunityBio, Inc.
|
165,954 | $1,452,927 | |
| 8 | AVXL |
Anavex Life Sciences Corp.
|
504,000 | $1,305,360 |
All Filings in ARWR
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,473,991 | 30,352 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $967,210 | 15,426 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $714,555 | 10,763 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $371,215 | 10,763 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $177,955 | 11,263 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $142,891 | 11,216 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $210,860 | 11,216 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $219,752 | 11,345 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $295,558 | 11,372 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $324,524 | 11,347 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $362,028 | 11,831 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $316,582 | 11,782 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $420,146 | 11,782 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $299,593 | 11,795 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $478,405 | 11,795 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $389,824 | 11,795 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $404,281 | 11,482 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $530,908 | 11,544 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $766,229 | 11,557 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $714,448 | 11,444 | Shares | Sole | 2021-10-14 | |
| 2020-06-30 | $9,890 | 229 | Shares | Sole | 2020-08-17 | |
| No filing history on record for this holder in this stock. | ||||||